SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________
SCHEDULE 13D/A2 (Amendment No. 2)
Under the Securities Exchange Act of 1934
GlycoGenesys, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.01 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
37989P10
--------------------------------------------------------------------------------
(CUSIP Number)
William F. Daniel
Elan Corporation, plc
Lincoln House
Lincoln Place
Dublin 2, Ireland
(353) 1-709-4000
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
February 18, 2004
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box [ ].
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5
--------------------------------------------------------------------------------
CUSIP No. 37989P10
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSONS
Elan Corporation, plc
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
N/A
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) SOURCE OF FUNDS (See Instructions)
WC, OO
--------------------------------------------------------------------------------
(5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
Ireland
--------------------------------------------------------------------------------
Number of (7) SOLE VOTING POWER
Shares 0
--------------------------------------------------------------
Beneficially (8) SHARED VOTING POWER
Owned 12,523,328
--------------------------------------------------------------
by Each (9) SOLE DISPOSITIVE POWER
Reporting 0
--------------------------------------------------------------
Person With (10) SHARED DISPOSITIVE POWER
12,523,328
--------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,523,328
--------------------------------------------------------------------------------
(12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(See Instructions) [ ]
--------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
20.7%
--------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON (See Instructions) CO
--------------------------------------------------------------------------------
Page 2 of 5
--------------------------------------------------------------------------------
CUSIP No. 37989P10
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSONS Elan International Services, Ltd.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
N/A
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) SOURCE OF FUNDS (See Instructions)
WC, OO
--------------------------------------------------------------------------------
(5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda
--------------------------------------------------------------------------------
Number of (7) SOLE VOTING POWER
Shares 0
--------------------------------------------------------------
Beneficially (8) SHARED VOTING POWER
Owned 12,523,328
--------------------------------------------------------------
by Each (9) SOLE DISPOSITIVE POWER
Reporting 0
--------------------------------------------------------------
Person With (10) SHARED DISPOSITIVE POWER
12,523,328
--------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,523,328
--------------------------------------------------------------------------------
(12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(See Instructions) [ ]
--------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
20.7%
--------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON (See Instructions) CO
--------------------------------------------------------------------------------
Page 3 of 5
Item 1. Security and Issuer.
Item 1 of Schedule 13D is hereby amended and restated in its entirety as
follows:
This Amendment No. 2 amends Schedule 13D filed with the Securities and
Exchange Commission (the "Commission") on January 22, 2004, as amended by
Schedule 13D/A1 filed with the Commission on February 3, 2004 (as so
amended, the "Schedule 13D"), by Elan Corporation, plc, an Irish public
limited company ("Elan"), and its direct wholly-owned subsidiary, Elan
International Services, Ltd., a Bermuda exempted limited liability company
("EIS"), with respect to the common stock, $0.01 par value (the "Common
Stock"), of GlycoGenesys, Inc. (the "Issuer"), a Nevada corporation whose
principal offices are located at Park Square Building, 31 St. James Avenue,
8th Floor, Boston, Massachusetts 02116.
Item 5. Interest in Securities of Issuer.
Item 5 of Schedule 13D is hereby amended and restated in its entirety as
follows:
(a) As of February 20, 2004, Elan (indirectly) and EIS (directly) each
beneficially owned 12,523,328 shares of Common Stock, representing 20.7% of the
outstanding shares of Common Stock (based on 49,636,397 shares of Common Stock
outstanding on January 15, 2004, plus 10,774,027 shares issuable upon exercise
or conversion of the Warrants, the Series A Preferred Stock, Series B Preferred
Stock, including 412,065 shares issuable upon conversion of accrued but unpaid
dividends on the Series B Preferred Stock as of February 20, 2004, and the
Series C Preferred Stock).
(b) As of February 20, 2004, each of Elan and EIS has the shared voting and
dispositive power over 12,523,328 shares of Common Stock. Neither Elan nor EIS
has sole voting or dispositive power over shares of Common Stock.
(c) On February 18, 2004, EIS sold an aggregate of 974,605 shares of Common
Stock in open market transactions as listed below:
------------------------------------------------------------------------
Date of Sale Amount Price Per Share
2/18/04 574,605 $1.30
2/18/04 100,000 $1.28
2/18/04 100,000 $1.27
2/18/04 200,000 $1.26
------------------------------------------------------------------------
(d) Not applicable.
(e) Not applicable.
Page 4 of 5
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief, the
undersigned certifies that the information set forth in this statement is true,
complete and correct.
Dated: February 20, 2004
ELAN CORPORATION, PLC
By: /s/ William F. Daniel
---------------------------------
Name: William F. Daniel
Title: Executive Vice President
and Secretary
Dated: February 20, 2004
ELAN INTERNATIONAL SERVICES, LTD.
By: /s/ Kevin Insley
---------------------------------
Name: Kevin Insley
Title: President and Chief
Financial Officer
Page 5 of 5